4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
4d Pharma PLC (AIM: DDDD) Participation in Chardan Microbiome Summit
4d Pharma PLC (AIM: DDDD) Parkinson’s trial receives FDA IND clearance
4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029 for the treatment of Parkinson’s disease
4d Pharma PLC (AIM: DDDD) Restatement of Interim Results to June 30, 2021
4D pharma to Restate Unaudited Interim Financial Statements for the Six-Month Period Ended June 30, 2021 to Correct Accounting for Warrants
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 14th February 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Audioboom, Cloudbreak, Cobra, Cizzle, Caracal, Ixico, Kibo, Live,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Sunday 13th February 2022 via Vox Markets.
Zak Mir takes a charting look at some of the most followed small caps. Today’s selection includes Alba, Arrow, Atlantic, Cobra, Deltic, Empire, Live, Omega, Predator, Petrotal, Premier.
RNS Hotlist with Zak Mir: GGP, ARV, BRSD, HEMO, LVCG, DKL, DNL, PTAL, NNN, TOM, GCAT, SVML, JDE, 88E, UFO & FDBK
A company which some in the market are suggesting could be bigger than Greatland Gold (GGP), Artemis Resources (ARV), said that exploration drilling has commenced at the Chapman Discovery, part
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday, 8th February 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes African Pioneer, Beowulf Mining, Cyba, Eurasia, GCM, Ixico,
4d Pharma PLC (DDDD.L) Appoints John Doyle as Chief Financial Officer
Leeds, UK, January 4, 2022, – 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic Products (LBPs), a novel class of drug derived
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 13th December 2021 via Vox Markets
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Blue, Challenger, Eve, Feedback, Hemo, Live, Midatech, MyHealth, Nanosynth,
4d Pharma PLC (DDDD.L) Phase 1/2 asthma study Part A results
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma
4d Pharma PLC (DDDD.L) 4D pharma presents IBS Phase 2 microbiome analysis
4D pharma presents microbiome analyses from Phase II clinical trial of Blautix® for IBS-C and IBS-D at Gastro 2021
